Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 ,inter alia, to consider and approve Intimation of Board Meeting to ....

Date: 27th August 2026 BSE Limited Phiroze Jeejeebhoy Towers 21st Floor, Dalal Street, Mumbai – 400001 BSE Scrip Code: 524322 Subject: Intimation of Board Meeting to be held on 02 nd September 2026 Dear Sir/Madam, Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on 02nd September 2026 at the Corporate Office of the Company situated at Chennai, inter-alia, to consider and approve the following business: 1. To approve Director’s Report and Corporate Governance Report for the financial year ended 31st March 2026. 2. To approve closure of Register of Members and Share Transfer Books of the Company for Annual General Meeting (AGM) purpose. 3. To approve the Cut-off date to record the entitlement of shareholders to cast their votes for the Annual General Meeting (AGM). 4. To fix the Date, Time and Venue to convene the Annual General meeting of the Company & the draft Notice calling the Annual General Meeting (AGM). 5. To consider and approve appointment of scrutinizer for Annual General Meeting (AGM) purpose. 6. To consider and recommend the re-appointment of Mr. Kuniamuthur Nanjappan Anand (DIN: 03230186), Director of the Company, who retires by rotation at the ensuing Annual General Meeting 7. To consider and approve the appointment of Internal Auditors of the Company for the financial year 2026-2027. 8. To recommend the appointment of Ms. Moonam Kapoor (DIN: 09278005) as Director of the Company. 9. To recommend the appointment of Secretarial Auditor of the Company for the financial year 2026-2027 to 2030-2031. 10. Any other agenda with permission of chair. We request you to take the above information on records. Yours faithfully, For Aanjaay Industries Limited (Formerly known as Kabra Drugs Limited) Nanjappan Aravind Director DIN: 01895602